A.R.T. Advisors’s Avanos Medical AVNS Stock Holding History

A.R.T. Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,200	Closed	-$204K	–	1352
2017 Q2	$204K	Buy	+5,200	New	+$196K	0.01%	1153
2016 Q4	–	Sell	-8,800	Closed	-$305K	–	1274
2016 Q3	$305K	Buy	+8,800	New	+$308K	0.1%	341

Other funds holding AVNS

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

A.R.T. Advisors's AVNS Position: Q3 2017 in Review

A.R.T. Advisors sold out of Avanos Medical (AVNS) in Q3 2017, closing a stake of 5,200 shares — an estimated $204K sold.

A.R.T. Advisors first reported a position in AVNS in Q3 2016 and held it in 2 quarters. The position peaked at $305K in Q3 2016. 318 funds tracked by Wall St. Rank hold AVNS as of Q3 2017.

A.R.T. Advisors reported no remaining Avanos Medical position as of Q3 2017 after selling out during the quarter.
A.R.T. Advisors sold 5,200 Avanos Medical shares in Q3 2017, an estimated $204K.
A.R.T. Advisors first reported a position in Avanos Medical in Q3 2016 and held it in 2 quarters.
A.R.T. Advisors's Avanos Medical position peaked at $305K in Q3 2016.
318 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2017.

Based on A.R.T. Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.